Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

H. pylori test marketing agreement

Aug. 23, 1996

La Jolla seeks patent on MI risk factor identification method

Aug. 23, 1996

FDA grants marketing approval for Biopool's Chromolize tPA Assay Kit

Aug. 23, 1996

Calypte HIV-1 Urine EIA test approved by FDA

Aug. 23, 1996

NeoRx's Verluma approved for U.S. market

Aug. 23, 1996

Conceptus begins clinical testing of STARRT falloposcopy system

Aug. 16, 1996

Home Access HIV testing system cleared for marketing in U.S.

Aug. 16, 1996

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...